Business · 16/01/2004Updated: 10/17/2026 · 1 min read
FDA Approves Supplemental NADA for Ceftiofur Hydrochloride
Summary
The FDA has approved a supplemental new animal drug application (NADA) for ceftiofur hydrochloride injectable suspension, providing revised susceptibility information for food-animal pathogens.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →